AIM-NASH: First-Ever Digital Pathology Tool Approved by FDA for Liver Drug Trials
A major milestone for AI-driven drug development, the U.S. Food and Drug Administration (FDA) has officially qualified AIM-NASH, the first […]
METABOLIC-LIVER-DISEASE-RD
